Milner Institute hosts official opening of new Functional Genomics Screening Laboratory
Last week, we were delighted to launch the new Functional Genomics Screening Laboratory (FGSL) here at the Milner Therapeutics Institute in Cambridge, UK. The new lab will support world-class research and innovation in the rapidly advancing field of functional...
Milner Therapeutics Consortium renewed for five years
We are delighted that the Milner Therapeutics Consortium has been renewed until 2029, which will continue to provide opportunities for our academic and business communities to engage with pharma at an early stage. The Milner Therapeutics Consortium has been active...
Sir Tony Kouzarides attends Astex anniversary event, joining Lord Vallance to discuss opportunities in UK life sciences.
This week, Milner Institute Director Professor Sir Tony Kouzarides was pleased to attend a special event in celebration of Astex’s 25-year anniversary. The event showcased achievements the company has made since its formation, including three cancer drugs on the...
Milner Institute partners with Flagship Pioneering and CUHP to accelerate biotech research and innovation
We are delighted to announce a new collaboration with Flagship Pioneering and Cambridge University Health Partners (CUHP), to jointly advance breakthrough scientific research and technologies. The collaboration will focus on research and innovation and will enable...